Sunderkötter Cord H, Tomimori-Yamashita Jane, Nix Verena, Maeda Solange M, Sindrilaru Anca, Mariano Mario, Sorg Clemens, Roth Johannes
Institute of Experimental Dermatology, University of Münster, Münster, Germany.
Immunology. 2004 Apr;111(4):472-80. doi: 10.1111/j.0019-2805.2004.01836.x.
Macrophages are decisive cells for the course of leprosy as they phagocytose Mycobacterium leprae and have the potential to influence the specific immune response. Expression and release of the myeloid-related protein (MRP) 8 and MRP14 (S100A8 and S100A9) characterize a proinflammatory subtype of macrophage that is prominent in, for example, murine infection with lack of a T helper 1 cell response and in certain highly active chronic inflammations of mice and humans. We investigated cutaneous biopsies of the different forms of leprosy (41 untreated patients) including leprosy reaction type 1 (reversal reaction) and type 2 (erythema nodosum leprosum) (n = 18) for expression of MRP8 and MRP14 by subtypes of macrophages. Concomitantly we determined serum levels of MRP8 and MRP14 by sandwich enzyme-linked immunosorbent assay. Expression of MRP8 and MRP14 by CD68-positive macrophages was low in tuberculoid leprosy and rose significantly in borderline tuberculoid leprosy and especially in multibacillary forms, there being expressed by mycobacteria-loaded foam cells. A significant rise of MRP8 and MRP14 expression also occurred in lepra reactions compared to the corresponding non-reactional forms. In type 2 reactions this additional increase was associated with a significant elevation of serum levels. In type 1 it was associated with expression of MRP8 and MRP14 by epitheloid and giant cells, which so far were considered not to express both proteins. In conclusion, we present evidence that the two prominent proteins MRP8 and MRP14 can be re-expressed in vivo by tissue macrophages in chronic infection, that their increased expression is characteristic for a macrophage subtype associated with high inflammatory but low antimycobacterial activity in the absence of a T helper 1 response, and that their significant rise in serum during erythema nodosum leprosum bears diagnostic and pathophysiological relevance.
巨噬细胞是麻风病程中的决定性细胞,因为它们可吞噬麻风分枝杆菌,并有可能影响特异性免疫反应。髓样相关蛋白(MRP)8和MRP14(S100A8和S100A9)的表达和释放是巨噬细胞促炎亚型的特征,这种亚型在例如缺乏辅助性T1细胞反应的小鼠感染以及小鼠和人类的某些高度活跃的慢性炎症中很突出。我们研究了不同类型麻风(41例未经治疗的患者)的皮肤活检样本,包括1型麻风反应(逆转反应)和第2型(麻风结节性红斑)(n = 18),以检测巨噬细胞亚型中MRP8和MRP14的表达。同时,我们通过夹心酶联免疫吸附测定法测定了血清中MRP8和MRP14的水平。在结核样型麻风中,CD68阳性巨噬细胞中MRP8和MRP14的表达较低,在界线结核样型麻风尤其是多菌型中显著升高,由载有分枝杆菌的泡沫细胞表达。与相应的非反应性形式相比,麻风反应中MRP8和MRP14的表达也显著升高。在2型反应中,这种额外的增加与血清水平的显著升高有关。在1型反应中,它与上皮样细胞和巨细胞中MRP8和MRP14的表达有关,而迄今为止认为这两种细胞不表达这两种蛋白。总之,我们提供的证据表明,在慢性感染中,组织巨噬细胞可在体内重新表达两种重要蛋白MRP8和MRP14,它们表达的增加是巨噬细胞亚型的特征,该亚型在缺乏辅助性T1反应时具有高炎症但低抗分枝杆菌活性,并且在麻风结节性红斑期间它们在血清中的显著升高具有诊断和病理生理学意义。